Skip to main content

Baxter International Inc(BAX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low41.74
Day High42.78
Open:41.85
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
GlobeNewswire
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation
GlobeNewswire
Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients
GlobeNewswire
Spectral Medical Provides Tigris Trial Update
GlobeNewswire
Spectral Medical Provides November Tigris Trial Update
GlobeNewswire
Spectral Medical Provides Tigris Trial Update
PR Newswire
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Baxter Investors of a Lead Plaintiff Deadline of September 11, 2023
GlobeNewswire
CORRECTION – Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing
PR Newswire
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit
GlobeNewswire
Spectral Medical Inc. Closes C$6.1 Million Bought Deal Convertible Note Financing
PR Newswire
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit
TheNewswire.com
BAX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Baxter International Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important September 11 Deadline in Securities Class Action - BAX
TheNewswire.com
BAX DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Baxter International Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important September 11 Deadline in Securities Class Action - BAX
PR Newswire
SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 11, 2023 in the Class Action Filed on Behalf of Baxter International Inc.(BAX) Shareholders

Profile

Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.